PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419097
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1419097
Orthopedic Regenerative Surgical Products Market size was valued at USD 4,140.22 Million in 2022, expanding at a CAGR of 3.98% from 2023 to 2030.
Orthopedic regenerative surgical products have multiple applications, including as joint pain management, trauma healing, and rebuilding. Regenerative orthopedics aids in the treatment of musculoskeletal pain and discomfort as well as the improvement of orthopedic problems like ligament, tendon, muscle, bone, knee meniscus, spinal disc, and cartilage injuries.
The primary drivers of market expansion are the increased incidence of orthopedic diseases including arthritis, the development of new technologies, and the rise in orthopedic procedures. Furthermore, during the forecast period, rising R&D expenditures and activities are anticipated to fuel market expansion. The U.S. National Library of Medicine article states that Azienda Ospedaliero-Universitaria Consorziale Policlinico carried out a clinical trial on platelet rich plasma (PRP) injections in Italy in April 2021. Accurate drug dosage administration is also made possible by a number of advances, including reservoir-type orthobiologics and sophisticated, miniature ortho biologics patches. In addition, the introduction of technologies enabling targeted organ medicine delivery is expected to drive higher demand for orthobiologics throughout the course of the projection period. These factors is anticipated to propel the market growth.
Furthermore, the market demand is expected to be driven by technological advancements, the increasing use of emerging technologies, including stem cells, Visco supplements, and Platelet Rich Plasma (PRP) therapies, as well as an increase in R&D studies.
The Global Orthopedic Regenerative Surgical Products Market is segmented on the basis of Product, Application, End-User, and Region.
The market is divided into four categories based on Product: synthetic, cell-based, allografts, and Visco supplements products. The Visco supplements segment dominates the market. High knee osteoarthritis prevalence, other surgeries are boosting segment growth.
The market is divided into five categories based on Application: cartilage and tendon repair, orthopedic pain management, joint reconstruction, trauma repair, and others. The joint reconstruction segment dominates the market and is likely to maintain its dominance during the forecast period. The growing surgical procedures, regenerative solutions are likely to boost market growth.
The market is divided into three categories based on End-User: hospitals, ambulatory surgical centers (ASCs), and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. High demand from healthcare sector is expected to boost the market growth.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Orthopedic regenerative surgical products market is fairly competitive in nature. To keep a competitive advantage, major players in the industry are launching and developing new products, expanding their operations internationally, investing in research and development, and growing their distribution networks. Important companies are also implementing tactics, such partnerships and mergers and acquisitions, to increase their market share.
In May 2021, MiMedx collaborated with the Wake Forest Institute to conduct R&D in regenerative medicine, aiming to advance innovative biologics and regenerative science.
The scope of this report covers the market by its major segments, which include as follows: